Biotech company built around a Phase 2/3 ready asset from NIH / NCATS, cyclodextrin, for the treatment of Niemann-Pick C (NPC)
- Year invested 2014
- Investment Stage Early
- Sectors
- Investment Status Historic
- Website vtessepharma.com/
- Company Status Private (by Sucampo)